Pannex Therapeutics
Anti-addictive painkillers to save lives.
New York, United States · Founded 2020 · $250K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- pannextherapeutics.com
- Total Funding
- $250K
- Last Round
- $250K Convertible NoteJan 2022
- Rounds
- 2
About
Pannex Therapeutics is a preclinical-stage biopharmaceutical company developing a novel class of Pannexin 1 (Panx1) channel blockers for chronic pain treatment and opioid addiction prevention. The company's first-in-class small molecule platform targets a new pharmacological pathway with potential applications across multiple neurological disorders and cancer. Based in New York with roots in Chile.
Summary
Pannex Therapeutics is a Biotech company based in New York, United States, founded in 2020. It has raised $250K in total across 2 rounds, most recently a $250K Convertible Note round in Jan 2022. Investors include SOSV and IndieBio.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...